Ursodeoxycholic acid treatment for primary sclerosing cholangitis

被引：0

作者：

Mol, Bregje ^{[1
]}

van Munster, Kim ^{[1
]}

Weersma, Rinse ^{[2
,3
]}

Inderson, Akin ^{[4
]}

Boonstra, Kirsten ^{[5
]}

Drenth, Joost P. H. ^{[1
]}

van Meer, Suzanne ^{[6
]}

de Vries, Elsemieke S. ^{[7
]}

Spanier, B. W. Marcel ^{[8
]}

Vrij, Ton ^{[9
]}

Verlaan, Tess ^{[10
]}

van Duijn, Femke ^{[1
]}

Ponsioen, Willemijn ^{[1
]}

Beuers, Ulrich ^{[1
]}

Dijkgraaf, Marcel ^{[1
]}

Ponsioen, Cyriel ^{[1
]}

机构：

[1] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

[2] Univ Groningen, Groningen, Netherlands

[3] Univ Med Ctr Groningen, Groningen, Netherlands

[4] Leiden Univ, Med Ctr, Leiden, Netherlands

[5] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands

[6] Univ Med Ctr Utrecht, Utrecht, Netherlands

[7] Isala Clin, Zwolle, Netherlands

[8] Rijnstate Hosp, Arnhem, Netherlands

[9] Zorggroep Twente, Almelo, Netherlands

[10] Gelderse Vallei Hosp, Ede, Netherlands

来源：

JOURNAL OF HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-115-YI

引用

页码：S317 / S317

页数：1

共 50 条

[31] Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: A pilot study
Lindor, KD
Jorgensen, RA
Anderson, ML
Gores, GJ
Hofmann, AF
LaRusso, NF
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (03): : 511 - 515
[32] EFFECT OF URSODEOXYCHOLIC ACID IN PRIMARY SCLEROSING CHOLANGITIS - A CONTROLLED TRIAL
BEUERS, U
SPENGLER, U
KRUIS, W
AYDEMIR, U
HELDWEIN, W
WEINZIERL, M
PAPE, GR
SAUERBRUCH, T
PAUMGARTNER, G
HEPATOLOGY, 1991, 14 (04) : A64 - A64
[33] Dose effect of ursodeoxycholic acid used in the treatment of primary biliary cirrhosis and primary sclerosing cholangitis
Lindor, KD
Bile Acid Biology and Its Therapeutic Implications, 2005, 141 : 225 - 229
[34] Serum cytokine levels in patients with primary sclerosing cholangitis: Effect of treatment with ursodeoxycholic acid
Neuman, MG
Angulo, P
Malkiewicz, IM
Jorgensen, RA
Katz, GG
De Silva, JP
Lindor, KD
JOURNAL OF HEPATOLOGY, 2001, 34 : 213 - 213
[35] Is high-dose ursodeoxycholic acid effective for the treatment of patients with primary sclerosing cholangitis?
Chazouillères, O
Corpechot, C
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (05): : 248 - 249
[36] A PILOT-STUDY OF URSODEOXYCHOLIC ACID (URSO) IN TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
OBRIEN, CB
SENIOR, JR
HEPATOLOGY, 1988, 8 (05) : 1372 - 1372
[37] Is high-dose ursodeoxycholic acid effective for the treatment of patients with primary sclerosing cholangitis?
Olivier Chazouillères
Christophe Corpechot
Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 248 - 249
[38] Effectiveness of Ursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis with Ulcerative Colitis: A Pediatric Case
Fujita, Yuji
Sugaya, Takeshi
Inui, Ayano
Yoshihara, Shigemi
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 253 (02): : 109 - 112
[39] EFFECTS OF URSODEOXYCHOLIC ACID IN PRIMARY BILIARY-CIRRHOSIS AND PRIMARY SCLEROSING CHOLANGITIS
RAEDSCH, R
STIEHL, A
KOMMERELL, B
TRENDS IN BILE ACID RESEARCH, 1989, 52 : 367 - 371
[40] Ursodeoxycholic acid in the treatment of primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) in pregnancy.
Holtmeier, J
Leuschner, M
Holtmeier, W
Stiehl, A
Klein, R
Leuschner, U
HEPATOLOGY, 2002, 36 (04) : 491A - 491A

← 1 2 3 4 5 →